Mohamad Saimi, N. I. (2020). Development of aerosolized niosome formulation containing gemcitabine and cisplatin for in-vitro cytotoxicity against MRC5 and A549 cell lines.
Chicago Style (17th ed.) CitationMohamad Saimi, Norfatin Izzatie. Development of Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for In-vitro Cytotoxicity Against MRC5 and A549 Cell Lines. 2020.
MLA (8th ed.) CitationMohamad Saimi, Norfatin Izzatie. Development of Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for In-vitro Cytotoxicity Against MRC5 and A549 Cell Lines. 2020.
Warning: These citations may not always be 100% accurate.